Quantbot Technologies’s AbCellera Biologics ABCL Stock Holding History

Quantbot Technologies’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$628K	Buy	79,955 +45,419	+132%	+$222K	0.02%	817
2026 Q1	$121K	Buy	+34,536	New	+$124K	﹤0.01%	1287
2025 Q1	–	Sell	-5,739	Closed	-$16.8K	–	1420
2024 Q4	$16.8K	Buy	+5,739	New	+$16K	﹤0.01%	1364
2023 Q3	–	Sell	-66,799	Closed	-$432K	–	1489
2023 Q2	$432K	Sell	66,799 -19,830	-23%	-$135K	0.03%	723
2023 Q1	$653K	Buy	86,629 +69,417	+403%	+$630K	0.05%	533
2022 Q4	$174K	Sell	17,212 -69,248	-80%	-$800K	0.01%	956
2022 Q3	$855K	Buy	86,460 +21,351	+33%	+$234K	0.06%	432
2022 Q2	$693K	Buy	+65,109	New	+$551K	0.06%	468
2021 Q2	–	Sell	-435	Closed	-$14K	–	1412
2021 Q1	$14K	Buy	+435	New	+$17.3K	﹤0.01%	1212

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Quantbot Technologies's ABCL Position: Q2 2026 in Review

Quantbot Technologies increased its AbCellera Biologics (ABCL) stake by 132% in Q2 2026, buying an estimated $222K and bringing the position to 79,955 shares worth $628K. The position accounts for 0.02% of the portfolio, ranked #817.

Quantbot Technologies first reported a position in ABCL in Q1 2021 and has held it in 9 quarters since. The position peaked at $855K in Q3 2022. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

Quantbot Technologies held 79,955 shares of AbCellera Biologics worth $628K as of Q2 2026.
Quantbot Technologies bought 45,419 AbCellera Biologics shares in Q2 2026, an estimated $222K.
AbCellera Biologics made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #817 holding.
Quantbot Technologies first reported a position in AbCellera Biologics in Q1 2021 and has held it in 9 quarters since.
Quantbot Technologies's AbCellera Biologics position peaked at $855K in Q3 2022.
151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.